The FDA has approved the first blood test for diagnosing Alzheimer’s disease, which could speed the path to treatment for ...

The platform, which is still in its pre-launch phase, aims to do more than just create another app — it will change the way ...

After a patient died following a high dose of Neurogene’s Rett syndrome gene therapy candidate, the biotech is sharing ...

The grant would have used artificial intelligence to shorten drug development and provide affordable drugs, vaccines and diagnostics.

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

The American Society of Gene and Cell Therapy (ASGCT) meeting is off and running in New Orleans! Kevin Davies, PhD, editorial director and Julianna LeMieux, PhD, deputy editor in chief at GEN are on ...

Biotech, one of the Bay Area's most important industries, sprang up in five short decades. Here are the key moments to know ...

Plus: NTxBio to invest $31 million to build biomanufacturing facility in Plano and Vonlane to launch nonstop service from ...

New York has added $10 million to its NYFIRST program to attract top research talent and boost biotech innovation, among other goals.

Rocket Pharmaceuticals has shared early data from three patients that tie its gene therapy for an inherited heart disease to ...

Awarded earlier this year, the $44M Birmingham Biotechnology Hub grant was set to support the growth of Alabama's ...

The star of the acquisition is the enzyme replacement therapy INZ-701, being developed for the rare disease ENPP1 deficiency.